Abstract
Compounds belonging to the stilbene family have gained remarkable significance in pharmaceutical as well as material chemistry. The current review covers the various synthetic approaches for the syntheses of stilbene scaffold and related structures over last 30 years. In addition, this review also highlights the role of stilbene intermediates used in the synthesis of important molecules with diverse applications in the field of pharmaceutics and material science.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Nature has been a source of medicinal compounds for thousands of years and large number of drugs have been isolated from natural products [1, 2]. Stilbene (1,2-diphenylethene) does not exist in nature itself, but its derivatives as plant secondary metabolites are present in various plant species and some of them are considered phytoalexins [2,3,4,5]. Stilbene and its analogues hold enormous potential importance due to their diverse spectrum of biological applications such as anticancer [6,7,8,9,10], antiproliferative [11, 12], antiangiogenesis [11, 12], antimicrobial [13,14,15,16,17], antileukemic [17, 18], antioxidant [17, 19, 20], anti-inflammatory [17], anti-HIV [21, 22], anti herpes simplex virus [23] and tyrosine kinase inhibitors [24, 25]. Stilbenes exist in E and Z conformations each eliciting different pharmacological activities. Research revealed that the E form or trans exhibits more potent anticancer activity compared to the Z form or cis form. The trans or E form is thermodynamically more stable. Many trans-stilbenes such as resveratrol 1, oxyresveratrol 2, pterostilbene 3, piceatannol 4, isorhapotigenin 5 and cis stilbene, combretastatin 6 (Fig. 1) exhibited varieties of biological activities [1, 4, 25]. Hydroxy stilbene, i.e., resveratrol (3,4,5-trihydroxystilbene), a non-flavonoid polyphenolic present in grapes, peanuts, berries and red wine was investigated due to its role in plants’ defense against pathogens and pharmacological properties [26,27,28,29,30,31,32]. It shows significant effect against cancer, AIDS, antagonistic activity against aryl hydrocarbon receptor (AhR) and estrogenic potency [33, 34]. Pterostilbene is used in the treatment of resistant hematology malignancies, diabetes and as antitumor agent [34].
Combretastatin A-4 (CA-4), a vascular disrupting agent (VDAs) and a vascular targeting agent (VTAs) present in the bark of Combretum caffrum, acts as antimitotic and exhibited antineoplastic, antioxidant and antiestrogenic properties [1, 35,36,37].
The non-availability of naturally occurring stilbenes in sufficient quantities dictated the development of synthetic methodologies for their preparation at large scale [3] such as Wittig or Horner–Wadsworth–Emmons (HWE) olefination, Perkin aldol condensation, transition metal coupling, i.e., Mizoroki–Heck, Negishi, Stille, Sonogashira, Suzuki–Miyaura, Grubbs & McMurry, Knoevenagel–Doebner, Ramberg–Bucklund reactions [7, 34, 38, 39]. Stilbene derivatives also show industrial applications in electrochemical, dyes, dye laser, coloring textiles, organic LED, fluorescent and optical brightners [40,41,42,43]. Likhitwitayawuid identified dimeric stilbenes as tyrosinase inhibitor [44], whereas Momotake and Arai wrote a review on photochemistry and photophysics of stilbene dendrimers and related compounds [45]. Shen et al. [46] presented an overview on natural stilbenes. Chaudhary et al. and Nam published reviews on Combretastatin A-4 analogues as anticancer and antimitotic antitumor agents, respectively [35, 36]. Recently, Reinisalo et al. [47] presented a review on polyphenol stilbenes, Jørgensen reviewed the photochemical oxidative cyclization of stilbenes and stilbenoids (the Mallory-reaction) [48], Savage et al. [49] presented a review of semi-rigid, stilbene-containing alternating copolymers, Chong et al. [50] contributed a review on metabolism and roles of stilbenes in plants, and Waldeck reviewed the photoisomerization dynamics of stilbenes [51]. The current review covers the synthetic strategies to develop convenient methods for the construction stilbene architecture and related analogues over the past few decades.
Synthetic strategies for stilbene analogues
Synthesis of stilbene analogues by the Wittig/Horner–Wadsworth–Emmons (HWE) reaction
Due to effective control of cancer by selenium-containing compounds, Yan et al. [30] prepared benzoselenazole-stilbene by the coupling of stilbene 10 with ebselen 11 as outlined in Scheme 1. For this purpose, phosphonate 8 was prepared in three steps by reacting nitrobenzaldehyde 7 with sodium borohydride in methanol, the resulting product was then treated with phosphorus tribromide in the presence of pyridine and finally refluxed with triethyl phosphite. Further, compound 8 was converted to amino stilbene 9 in 74% yield by reacting with benzaldehydes followed by reduction of nitro group with stannous chloride. Amino stilbene 9 was subsequently coupled with 2-(chloroseleno)benzoyl chloride 10 in presence of sodium hydride to accomplish desired benzoselenazole-stilbene 11 in 55% yield.
Bhat and Pezzuto [52] described chemotherapeutic property of stilbene-based resveratrol. Thus, keeping in mind the perspective applications of resveratrol, Paul et al. [53] synthesized both cis 15 and trans-stilbenes 16 via a Wittig reaction between phosphonium salt 13, which is derived from compound 12 with appropriate aromatic aldehydes 14 but these stilbenes 15 and 16 were formed in 9–52% yields. Mizuno et al. [54] synthesized derivatives of pterostilbene by using a Wittig reaction similar to the route shown in Scheme 2.
Simoni et al. [26] prepared carbamates and uracil derivatives 20a–c from cis-stilbene to test their potential antitumor activity. The Wittig reaction of aldehyde 17 with Wittig salt 13, followed by reduction in the presence of Zn, generated hydrochloride salt 18 in 85% yield. Compound 18 was converted into intermediate isocyanate 19 by treating it with base and trichloromethyl chloroformate. The intermediate isocyanate 19 was finally converted into water soluble urea 20a and carbamates 20b–c in 70–89% yield as outlined in Scheme 3.
Roman et al. [8] prepared E and Z stilbenes as anti-invasive agents by different methods. E-stilbenes 24 were prepared in 48–99% yield using a Wittig reaction, in which benzyl bromide 21 was converted to phosphonate 22 and subsequently transformed to stilbenes 24 in an E/Z ratio 99:1 by reacting with benzaldehydes 23 under nitrogen atmosphere. A solvent-free Arbusov reaction generated triethylphosphite from benzyl bromide followed by a Horner–Wadsworth–Emmons reaction in (THF/KO\(^{\mathrm {t}}\)Bu) and afforded E-selectivity with higher yields as shown in Scheme 4a. Z-stilbenes 28 were formed in 13–87% yield through the Sonogashira coupling of phenylacetylene 25 with aryl iodides 26, which produced alkynes 27 in 92–99% yield. A wide range of alkynes 27 were converted into Z-stilbenes 28 via hydrosilylation (Chalk–Harrod mechanism) and TBAF mediated conversion of vinylsilanes. Lindlar’s catalyst also afforded the Z-stilbenes as shown in Scheme 4b.
Li et al. [5] followed the same Wittig–Horner reaction to generate hydroxy stilbenes 31 as severe acute respiratory syndrome (SARS) inhibitors. Phosphonates of 3,5-dimethoxybenzyl chloride 30 were obtained by an Arbuzov reaction in (n-Bu)\(_{{4}}\)NI. The reaction of phosphonate anion from compound 30 with aryl aldehydes gave E-stilbenes, which subsequently were demethylated to hydroxylated stilbenes 31 in quantitative yield as outlined in Scheme 5.
Gao et al. [17] synthesized radiolabeled stilbenes 33b and 34b as probes for cancer by treating Wittig salt 13 with 4-fluorobenzaldehyde 32b and 4-nitrobenzaldehyde 32a, respectively. Radiolabel precursors 33a and 34a were formed in 30–60% yield. Treatment of nitro precursors 33a and 34a with K\(^{{18}}\)F/Kryptofix\(^{2.2.2}\) afforded fluorine-18 stilbenes 33b and 34b in 15–20% radiochemical yield as shown in Scheme 6.
Das et al. [55] synthesized pinacolyl boronate stilbenes 38 as lipogenic inhibitors using a Wittig strategy. Wittig salt 36 was formed as white solid in 92% yield from 4,4,5,5-tetramethyl-2-p-tolyl-1,3,2-dioxaborolane 35 in two steps, bromination was followed by a Wittig reaction. Wittig salt 36 on treatment with aldehydes 37 afforded the final products 38 in 72–85% yield as outlined in Scheme 7.
Srivastava and Lee [56] reported the use of a Wittig reaction for the synthesis of hybrid stilbenes 43 and 44 bearing a quinoline moiety to test their anticancer activity. Wittig salt 42 was prepared from benzyl bromide 41 in 60–80% yield while quinoline-3-carbaldehydes 40 were synthesized in 15–89% yield from aniline 39 through a Vilsmeier–Haack reaction. The reaction of Wittig salt 42 with quinoline-3-carbaldehyde 40 resulted in cis-product 43 in 21–75% yield and trans-product 44 in 2–10% yield as described in Scheme 8.
Jung et al. [57] prepared stilbenes (E/Z ratio 1/1) derivatives 50–56 in 77–90% yield as tyrosine phosphatase 1B inhibitors from the reaction of protected aromatic aldehyde 49 and aromatic ylide 47. Deprotection of desired stilbene 50 was accomplished in 86% yield in the presence of tetrabutylammonium fluoride. The ester functionality of stilbene derivative 50 was reduced to stilbenes 52 and 53 and their subsequent deprotection afforded 54–56 in 77–90% yields as shown in Scheme 9a. Methyl-4-(chloromethyl) benzoate 57 was transformed into methyl-3[4-(iodomethyl)phenyl]-2-propenoate 60 in 90% yield via compounds 58 and 59. Phosphonium salt 61 was obtained in 91% yield from compound 60. Reaction of compound 61 with aldehyde 62 provided stilbene 63 in 62% yield. Final phenolic stilbene 64 was obtained in 28% yield by demethylation of stilbene 63 as shown in Scheme 9b. In continuation of their work, Jung et al. [58] obtained amides 65–66 by treating compound 51 with amines. Subsequent deprotection afforded E-stilbenes 67-68 in 60–74% yield as shown in Scheme 9c, and their antioxidant and neuroprotective potential was also evaluated.
Achalkumar and Yelamaggad [59] first reported the coupling of cyclohexane-1,3,5-trione with E-stilbenes 72 and 75 to form light emitting tris(N-salicylideneaniline) [TSANs] 77-78 as shown in Scheme 10. Diethyl(4-nitrobenzyl)phosphate 70 was prepared in 70% yield in two steps from 4-nitrotoluene 69 by benzylic bromination and a Michalis–Arbuzov reaction. The intermediate 70 furnished 1,2-bis(alkoxy)-4-(4-nitrostyryl)-benzenes 72 in 60–62% yield by a HWE reaction with 3,4-dialkoxybenzaldehydes 71 and subsequent reduction using indium as a source of reducing agent. 3,4,5-Trialkoxy aldehyde 74 was obtained in 68–80% yield by lithium aluminum hydride mediated reduction of the ester functional group of 73 into alcohols followed by oxidation of alcohols into aldehydes using PCC as oxidizing agent. The reaction of aldehyde 74 with intermediate 70 resulted in a nitrostilbene followed by reduction of nitro group to amine 75 in 60–64% yields. Finally, treatment of triformylphloroglucinol 76 with stilbenes 72 and 75 gave desired TSANs 77 and 78, respectively, in 60–71% yields as yellow crystals.
Belluti et al. [60] understood the biological importance of stilbene analogues and coumarins; therefore, they embedded coumarin units in various stilbene analogues. Methylcoumarines 79 generated intermediate phosphonic acid diethyl esters 80 in 60–81% yield. The intermediate 80 underwent HWE reaction with aldehydes, which afforded stilbene derivatives 81 in an E/Z ratio of 9/1 in 51–72% yield as outlined in Scheme 11.
McNulty and McLeod [61] investigated two Wittig routes for the synthesis of stilbene analogue E-pterostilbene 88. Classical Wittig olefination usually yields poor E/Z stereocontrol, and it is highly desirable to improve stereoselectivity. In route A, phosphonium salt 86 was prepared from 3,5-dihydroxybenzoic acid 82 by converting acid 82 into ester 83 in 95% yield. Reduction of ester 83 into corresponding alcohol 84 was accomplished in 92% yield, which on direct reaction with triphenylphosphine HCl or through formation of benzyl chloride 85 (93% yield) gave compound 86 in 99% yield. However, compound 86 failed to react with 4-hydroxybenzaldehyde 87a, but after protection of hydroxyl group 87b–d gave pterostilbenes 3, 88a-c in 91% yield as shown in Scheme 12a. In route B, p-hydroxyphosphonium salt 90 was obtained in 91% yield using the above procedure. However, protection of the hydroxy group was required for the reaction of phosphonium salt 90 with an aldehyde. Here a deprotected phosphonium salt does not react with an aldehyde. Final product 3 was obtained in an E/Z ratio of 95/5 in 91% yield as shown in Scheme 12b.
Anthracene-based stilbene derivatives 96 containing a 1,3,4-oxadiazole moiety were synthesized by Li and He [62] as shown in Scheme 13, and they also evaluated their optical properties. Anthracene-substituted 1,3,4-oxadiazole intermediate 94 was obtained in 78% yield by refluxing 4-methylbenzohydrazide 91 with anthracene-9-carbaldehyde 92 giving a yellow solution 93 to which chloramines-T were added and brominated with NBS to furnish compound 94. Compound 94 furnished phosphonate ester 95 in 95% yield which, followed by a HWE reaction with aromatic aldehydes, afforded desired products 96 in 83–93% yield.
Lu and He [63, 64] synthesized 1,3,4-oxadiazole derivatives containing stilbene and naphthalene units 101 from azomethine. Azomethine 98 was prepared from hydrazide 91 and aldehyde 97 [62]. Reaction of azomethine 98 with chloramine-T gave an intermediate having an oxadiazole ring. Bromonation afforded an oxadiazole bearing benzyl bromide 99. Esterification of compound 99 followed by a Wittig–Horner reaction furnished product 101 in 81–91% yield as showed in Scheme 14.
Zhu et al. [43] synthesized conjugated stilbenes carrying an oxadiazole moiety 107 to study their optical properties. Oxadiazole 104 was formed in 60% yield by direct reaction of p-toluic acid 102 with hydrazine hydrate 103 in the presence of polyphosphoric acid. Bromination of oxadiazole 104 followed by esterification with triethylphosphate afforded 106 in 80% yield. A Horner–Wadsworth–Emmons reaction of phosphonate ester 106 with appropriate aldehydes gave target stilbenes carrying an oxadiazole moiety 107 in 92% and 93% yield as outlined in Scheme 15a. In continuation of his work, Zhu et al. [65] synthesized two novel UV protectant compounds 109 in 35% yield and 68% yield by treating phosphonate ester 106 with respective aldehydes 108 under HWE reaction conditions as shown in Scheme 15b.
Hahm et al. [66] reported the synthesis of photosensitive polyimide (PSPI), ODPA-stilbene PSPI 115 that could be used as a liquid crystal display. (4-Nitrobenzyl)triphenylphosphonium bromide 111 was prepared from 4-nitrobenzyl bromide 110 in 83% yield. The subsequent reaction of compound 111 with 4-nitrobenzaldehyde gave \(4{,}4^\prime \)-dinitrostilbene 112 in 54% yield, which followed by nitro reduction with \(\hbox {SnCl}_{{2}}\) produced \(4,4^\prime \)-diaminostilbene 113 in 52% yield. Hybrid ODPA-stilbene 115 was formed when ODPA reacted with compound 113 under a nitrogen atmosphere in dry NMP as shown in Scheme 16.
Metal-mediated syntheses of stilbene analogues
Considering the importance of quinazoline and stilbene as bioactive compounds, Mahdavi et al. [67] hybridized trans-stilbene with quinazolines to develop potent anticancer agents. The reaction of styrene 117 with bromobenzaldehyde 116 using palladium-catalyzed Mizoroki–Heck reaction conditions provided stilbene 118 in 90% yield. Treatment of isatoic anhydride 119 with relevant primary amines generated anthranilamide 120 in 85–95% yield, which on reflux with stilbene 118 furnished 121 in 90–95% yields. As described in Scheme 17, compound 121 was oxidized to quinazoline 122 in 75–90% yield using tetrabutyl ammonium bromide in the presence of base.
As indicated in Scheme 18, Marti-Centelles et al. [68] described palladium-catalyzed preparations of stilbenes 124 by the reaction of styrene 117 with halogenated derivatives 123 under two different reaction conditions (Methods A and B). Both methodologies afforded desired stilbenes in good yields (65–97%).
A relatively new route to synthesize antitubulin agent, biaryl aryl stilbene 131 by utilizing Suzuki and Mizoroki–Heck cross coupling reactions, was disclosed by Kumar et al. [10]. Bromination of 3,4,5-trimethoxybenzaldehyde 125 followed by Suzuki cross coupling with aryl boronic acids 127 produced intermediate 4,5,6-trimethoxybiphenyl-2-carbaldehyde 128 in 88–95% yield. Wittig reaction of aldehyde 128 furnished 2,3,4-trimethoxy-6-vinylbiphenyls 129 followed by palladium-catalyzed Mizoroki–Heck coupling with aryl halides 130 afforded biaryl stilbene 131 in 88–90% yield as shown in Scheme 19a. Reddy et al. [69] synthesized nitrovinyl stilbenes 133 by using a similar methodology. Intermediate 126 produced stilbene 132 in 84–97% yield by way of a palladium-catalyzed Mizoroki–Heck reaction with styrene. The reaction of compound 132 with nitromethane gave nitrovinyl stilbenes 133 in 79–96% yield as shown in Scheme 19b.
Albert et al. [70] followed a Mizoroki–Heck reaction protocol using triethanolamine, which acts as ligand, solvent as well as base [71] allowing the economic synthesis of E-stilbenes 3, 137 to evaluate their antimicrobial activity. Substituted styrenes 135 were synthesized in 58–75% yield from benzaldehyde 134 by a Wittig reaction. Then, a Mizoroki–Heck reaction between styrene 135 and halogenated benzene 136 gave E-stilbenes 3, 137 in good yields as outlined in Scheme 20.
Khan et al. [72] synthesized stilbene derivatives 139 in 40–89% yields by mesylation of 2-iodobenzyl alcohol 138 with dimethylmalonate, which gave intermediate in 68% yield followed by a Mizoroki–Heck reaction with styrenes then gave stilbenes 139 as shown in Scheme 21. Further stilbene derivatives 139 were used in iodonium-promoted carbocyclizations to furnish a mixture of structurally complex indanes 140a in 18–55% yields and tetrhydronaphthalenes 140b in 18–59% yields with three new stereogenic centers.
Kabir et al. [13] reported the Pd-catalyzed regioselective synthesis of E-stilbene 144 in 74% yield by a Negishi cross coupling between arylvinyl iodide 143 and arylzinc reagent 142. Arylvinyl iodide 143 was prepared in 84% yield [73], whereas arylzinc 142 was obtained by transmetallation of hydrogen-lithium exchange product of arylbromide 141 with zinc(II)chloride as outlined in Scheme 22.
McDonald et al. [74] synthesized aza-stilbenes 147 to check their potency against the c-RAF enzyme. A range of styrenes 146 were created by the palladium-catalyzed Stille coupling of 5-bromo-nicotinonitrile 145 with tributylvinyl tin. Mizoroki–Heck cross coupling of substituted styrenes 146 with bromo benzene furnished aza-stilbenes 147 mostly in moderate yields as shown in Scheme 23.
Lara-Ochoa et al. [75] reported a new route to stilbene analogue resveratrol 1 using a Sonogashira coupling strategy. Acetylene precursor 150 was obtained in 93% yield under Sonogashira coupling conditions. Subsequent hydrogenation of acetylene 150 with \(\hbox {LiAlH}_{{4}}\) gave an E/Z mixture of 16, 17 (96/4 ratio) in quantitative yields. Diphenyldisulfide-assisted isomerization of an E/Z mixture of 16 and 17 gave trans-isomer 17 in 95% yield. Deprotection of the methoxy functional group in 17 in the presence of boron tribromide gave resveratrol 1 in 70% yield as described in Scheme 24.
Utilization of cyclic 1,1-bis(silyl)alkenes 151 to graft double bond on the aromatic ring for the selective preparation of E-stilbenes 154 was reported by Pawluc et al. [76]. Treatment of 151 with various aryl iodides 152 under Mizoroki–Heck coupling conditions furnished compounds 153 in good yields. Various E-stilbenes 154 were formed in good yields (62–92%) when compounds 153 were further coupled with various aryl iodides 152 using \([\hbox {Pd}(\hbox {C}_{{3}}\hbox {H}_{{5}})\hbox {Cl}]_{{2}}\) as a catalyst in the presence of TBAF shown in Scheme 25.
An efficient one-pot preparation of stilbene 154 under Mizoroki–Heck reaction conditions was presented by Saiyed and Bedekar [77]. This method reduces work-up, generates less waste and saves time and energy. Initially, styrene 117 was generated by dehydrohalogenation of (2-bromoethyl)benzene 156, whereas the same styrene 117 can also be accessed from aldehyde 157 and phosphonium salt 42 using a Wittig reaction protocol as described in Scheme 26. Product 154 was obtained in 54-88% yield using a standard Mizoroki–Heck reaction as shown in Scheme 26.
Understanding the importance of sonochemistry in accelerating synthetic reactions, Cella et al. [78] utilized ultrasound to generate stilbenes from organotellurium compounds and potassium organotrifluoroborate salts under Suzuki cross coupling reaction conditions. Z-stilbenes 160 were obtained in 60–82% yield by ultrasound irradiation of Z-styryl n-butyltelluride 158 and potassium organotrifluoroborate 159 using \(\hbox {Pd}(\hbox {PPh}_{{3}})_{{4}}\) and \(\hbox {Ag}_{{2}}\hbox {O}\). Whereas E-stilbenes 163 have been prepared by using E-styryltrifluoroborate 161 and n-butyl(aryl)tellurides 162 with potassium carbonate in 59–91% yield as shown in Scheme 27.
Copolymerization of benzotriazole (BTz) 166, thiophene 168 and stilbene 167 was carried out by Karakus et al. [79] to study their electrochemical properties via Stille cross coupling reaction. Copolymers 169 (\(\hbox {P}_{{1}}\), \(\hbox {P}_{{2}}\) and \(\hbox {P}_{{3}})\) were synthesized in different ratios of BTz and stilbene. Coupling of 4,7-dibromo-2-dodecylbenzotriazole 166, E-1,2-bis(4-bromophenyl)ethane 167 and 2,5-bis(tributylstannyl)thiophene 168 using dichlorobis(triphenylphosphine)-palladium(II) gave the desired copolymers 169 (\(\hbox {P}_{{1}},\hbox { P}_{{2}}\) and \(\hbox {P}_{{3}})\) as shown in Scheme 28.
Zhang et al. [80] reported an efficient and simple method to synthesize 2-hydroxylated (E)-stilbenes 172 in good yield by oxidative coupling of 2-hydroxystyrene 170 with arylboronic acid 171 using \([\hbox {CpRhCl}_{{2}}]_{{2}}\) and \(\hbox {Cu(OAc)}_{{2}}\) at room temperature as shown in Scheme 29, and they further investigated their antiproliferative activity.
Novel double carbocyclizations mediated by selenium were reported by Shahzad and Wirth [81]. Stilbenes 174 were generated from methyl-2-iodobenzoate 173 under palladium-catalyzed Mizoroki–Heck reaction conditions. Reduction of 174 and mesylation of compound 175 followed by subsequent nucleophilic substitution reaction furnished stilbenes 176. On the other hand, 2-iodobenzyl chloride 177 also gave stilbenes 176 using the same route through compound 178. These substituted stilbenes 176 were used as precursors to produce dihydronaphthalene 179 in 50–90% yields, which was then transformed to benzofluorenes 180 in 30–90% yields through a one-pot procedure using phenylselenium chloride as selenylating reagent with a Lewis acid as shown in Scheme 30a.
Shahzad et al. [82] used a malonate moiety on an alkene to synthesize dihydronaphthalene and benzofluorenes. Stilbenes 174 were obtained in 80–93% yields from methyl 2-iodobenzoate 173 under Mizoroki–Heck reaction conditions. Hydrolysis of 174 afforded carboxylic acids 175 in 87–100% yields. \(\beta \)-keto ester derivatives of stilbene 181
were obtained in 58–98% yields from corresponding acids 175 using potassium ethyl malonate. Stilbene precursor 181 was transformed to dihydronaphthalene 182 in 50–96% yields using a combination of a selenium electrophile as selenylating reagent with a Lewis acid as shown in Scheme 30b.
Shahzad et al. [83] also used diselenide and disulfide in the synthesis of isocoumarins 184. Stilbene-based carboxylic acids 175 were obtained in 87–100% yields from corresponding esters by using lithium hydroxide. Compound 175 and its analogues were cyclized to dihydroisocoumarins 183 in 50–97% and isocoumarins 184 in 81–99% yields using N-phenylselenosuccinimide (N-PSS). Because of the high cost of N-phenylselenosuccinimide (N-PSS), another methodology was developed by Shahzad and coworkers using diphenyl diselenide and [bis-(trifluoroacetoxy)iodo]benzene to synthesize isocoumarins 184. Optimization concluded that 10 mol% use of catalyst diphenyl diselenide gave desired isocoumarins in excellent yield as shown in Scheme 30c.
Synthesis of stilbene analogues by Perkin condensation
Kachhadia et al. [84] designed stilbene-based hydroxamates 190 to inhibit histone deacetylases (HDACs), which are the cause of epigenetic states related to cancer. For this purpose, 4-formylcinnamic acid was converted to ester 186, which undergoes Perkin condensation with substituted phenylacetic acids 185 to generate acrylic acids 187 in 47% yield. Compounds 187 were then reduced to alcohols and oxidized into aldehydes 188 in 28% yield using PCC. Compound 188 underwent reductive amination to amine 189. The amines were finally converted into hydroxamic acid 190 in 95–96% yield by treating with hydroxylamine as shown in Scheme 31.
To assess the cytotoxicity of stilbene derivatives, efficient preparation of resveratrol analogue 195 was described by de Lima et al. [1] using Perkin reaction conditions. Condensation of aldehydes 191a–d with phenyl acetic acid 185 provided carboxylic acid-substituted stilbenes 192a–d in 48–49% yields. Compound 194 was formed in 78% yield when copper chromite in quinoline was used for the decarboxylation of compound 192b. Compound 194 was isomerized to trans-analogue 195 in 98% yield in the presence of concentrated HCl. Hydrolysis of compound 192a under basic conditions generated compound 193 in 95% yield as outlined in Scheme 32.
Other synthetic methodologies
Chanawanno et al. [85] prepared and studied the antibacterial activity of pyridinium stilbene 199a, 199b and quinolinium stilbene 203a, 203b. 1,2-Dimethylpyridinium iodide 196 reacted with 4-dimethylaminobenzaldehyde 198 and 4-ethoxybenzaldehyde 197 separately to produce PAM 199a in 61% yield and PET 199b in 66% yield. Replacement of pyridinium iodide 196 with quinolinium iodide 202 generated QAM 203a in 89% yield and QET 203b in 54% yield. When stilbenes 199 and 203 were stirred with a silver salt of 4-substituted benzene sulfonates 200, benzenesulfonates 201, hybrid stilbenes with counter anions were formed in 66–91% yields and 204 in 54–89% yields as shown in Scheme 33.
Xiao et al. [4] reported the creation of hybrid structure coumarin-stilbenes 208 by locking the stilbene double bond in the benzopyrone ring and also studied their antitumor properties. 3-Arylcoumarins 207 were formed in 74–93% yield from substituted phenylacetic acids 205 and o-hydroxybenzaldehyde 206. Hydrolysis of compounds 207 with HCl afforded compounds 208 in 90–95% yield as shown in Scheme 34.
Pratap et al. [3] reported the synthesis of stilbenes 211 in 26–81% yield and 212 in 60–65% yield (see Scheme 35) through a ring transformation between 4-phenyl-3-buten-2-one 210 and 2H-pyran-2-one 209 using KOH.
Giraud et al. [25] developed a new and efficient method to synthesize cis-stilbenes analogue 6 and 215 by hydrosilylation–protodesilylation of diarylalkynes by following the protocol shown in Scheme 36 instead of using Lindlar’s catalyst due to its drawbacks of isomerization and production of alkanes during the reaction. \(\hbox {PtO}_{{2}}\) proved to be an efficient catalyst for hydrosilylation. Hydrosilylation of diarylalkynes 213 was done using \(\hbox {PtO}_{{2}}\) and \(\hbox {HSiOEtMe}_{{2}}\). Removal of \(\hbox {HSiOEtMe}_{{2}}\) and protodesilylation of vinylsilane 214 with TBAF afforded Z-stilbenes 6 and 215 in 49–90% yield.
As shown in Scheme 37, Kumar et al. [86] performed microwave-assisted synthesis of hydroxylated stilbenes 217 in 56–91% yields from cinnamic acid derivatives 216 in a methyl-imidazole promoted decarboxylation.
Wyrzykiewicz et al. [27] introduced piperidine, morpholine and 4-methylpiperidine bearing stilbene moieties and also investigated their antimicrobial activity. Compounds 220 were formed in 13–78% yield by the reaction of E-4-(bromoalkoxy)stilbenes 218 and were treated with piperidine, morpholine and 4-methylpiperidine 219 separately. E-4-(bromoalkoxy)stilbenes 218 were prepared by a reported procedure [87] as shown in Scheme 38.
Chang et al. [88] synthesized sulfonyl (E)-stilbenes 222 in 57–88% yield from benzylic sulfones 221 by dimerizative desulfonation shown in Scheme 39. Different bases and additives were used for optimization, and results showed that NaH and \(\hbox {PhNO}_{{2}}\) gave good yields.
Because of the diverse applications of organosilanes in the chemical industry, Hussain et al. [89] synthesized silicone-based triazine–stilbene compounds 228 in three steps as shown in Scheme 40. In first step, the reaction of 4,4-diaminostilbene-2,2-disulfonic acid 223 with an ice-cold slurry of cyanuric chloride 224 generated intermediate 225. In the second step, intermediate 225 was condensed with aromatic amines at pH 6. In the final step, compound 226 reacted with 3-aminopropyltrimethoxy silane 227 to yield 228 in 92–94%. Um et al. [90, 91] used a similar methodology to synthesize triazine–stilbene as fluorescent brighteners.
Um et al. [41] prepared substituted triazine–stilbene 232 to test their brightness. Intermediate 230 was produced by reacting stilbene 229 with 2,4,6-trichloro-1,3,5-triazine 224 followed by treatment with different amines. Addition of phenolic derivatives to 231 gave products 232 in 70–98% yield as shown in Scheme 41.
Understanding the photophysical properties of stilbene, Buruiana et al. [92] prepared stilbene-containing polyacrylates 234. The monomers (SUM) 233 were produced in 96% yield by adding 2-isocyanatoethylmethacrylate to trans-4-stilbene methanol. SUM (monomers) 233 were copolymerized with methyl methacrylate (MMA) by free radical mechanism. Stirring the mixture of SUM and MMA in the presence of an initiator (AIBN) gave polyacrylate (SUMMA) 234 in 48% yield as shown in Scheme 42.
Conclusion
The significance of stilbenes and their related structures is prominent in the current literature such as publications, reviews, patents and books. In the last decade, different synthetic approaches have been devised to design novel stilbene-based compounds. The classical approaches involve famous named reactions such as the Wittig reaction/Horner–Wadsworth–Emmons reaction, Mizroki–Heck reaction, Suzuki cross coupling reaction, Stille cross coupling reaction, Sonogashira cross coupling reaction, and Perkin condensation to synthesize stilbenes and related structures. It must be highlighted that these reactions have changed the science of synthesis. The most essential synthetic methodologies to synthesize E and Z-stilbene analogues have been summarized in this article. However, in our view, there will be further developments for the production of novel stilbene-based structures in the coming years. We hope will be useful for the scientific community, especially for those interested in the synthesis of stilbene analogues, which have a wide spectrum of applications in medicinal and material chemistry.
References
de Lima DP, Rotta R, Beatriz A, Marques MR, Montenegro RC, Vasconcellos MC, Pessoa C, de Moraes MO, Costa-Lotufo LV, Sawaya ACHF, Eberlin MN (2009) Synthesis and biological evaluation of cytotoxic properties of stilbene-based resveratrol analogs. Eur J Med Chem 44:701–707. doi:10.1016/j.ejmech.2008.05.003
Mochida S, Hirano K, Satoh T, Miura M (2010) Synthesis of stilbene and distyrylbenzene derivatives through rhodium-catalyzed ortho-olefination and decarboxylation of benzoic acids. Org Lett 12:5776–5779. doi:10.1021/ol1027392
Pratap R, Kumar R, Maulik PR, Ram VJ (2006) A non catalytic regioselective approach to the synthesis of (\(E)\)-stilbenes from suitably functionalized 2H-pyran-2-ones. Tetrahedron Lett 47:2949–2952. doi:10.1016/j.tetlet.2006.02.103
Xiao CF, Tao LY, Sun HY, Wei W, Chen Y, Fu LW, Zou Y (2010) Design, synthesis and antitumor activity of a series of novel coumarin–stilbene hybrids, the 3-arylcoumarins. Chin Chem Lett 21:1295–1298. doi:10.1016/j.cclet.2010.04.034
Li YQ, Li ZL, Zhao WJ, Wen RX, Meng QW, Zeng Y (2006) Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication. Eur J Med Chem 41:1084–1089. doi:10.1016/j.ejmech.2006.03.024
Inayat-Hussain SH, Thomas NF (2004) Recent advances in the discovery and development of stilbenes and lactones in anticancer therapy. Expert Opin Ther Pat 14:819–835. doi:10.1517/13543776.14.6.819
Hart JH (1981) Role of phytostilbenes in decay and disease resistance. Annu Rev Phytopathol 19:437–458. doi:10.1146/annurev.py.19.090181.002253
Roman BI, De Coen LM, Thérèse FC, Mortier S, De Ryck T, Vanhoecke BWA, Katritzky AR, Bracke ME, Stevens CV (2013) Design, synthesis and structure-activity relationships of some novel, highly potent anti-invasive (E) and (Z)-stilbenes. Bioorg Med Chem 21:5054–5063. doi:10.1016/j.bmc.2013.06.048
Gosslau A, Pabbaraja S, Knapp S, Chen KY (2008) Trans- and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells. Eur J Pharmacol 587:25–34. doi:10.1016/j.ejphar.2008.03.027
Kumar AS, Reddy MA, Jain N, Kishor C, Murthy TR, Ramesh D, Supriya B, Addlagatta A, Kalivendi SV, Sreedhar B (2013) Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents. Eur J Med Chem 60:305–324. doi:10.1016/j.ejmech.2012.12.008
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnworth NR, Kinghorn AD, Metha RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220. doi:10.1126/science.275.5297.218
Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK (2005) Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41. J Med Chem 48:4087–4099. doi:10.1021/jm0205797
Kabir MS, Monte A, Cook JM (2007) An efficient palladium-catalyzed Negishi cross coupling reaction with arylvinyl iodides: facile regioselective synthesis of \(E\)-stilbenes and their analogues. Tetrahedron Lett 48:7269–7273. doi:10.1016/j.tetlet.2007.08.04
Wieslaw P, Bogdan K (1999) Antimicrobial activity of some \(N\)-alkyl and \(N\)-nitrobenzyl substituted halides of (\(E)\)-\(4^\prime \)-hydroxy-\(3^\prime \)-methoxystilbazoles-4. IL Farmaco 54:584–587. doi:10.1016/S0014-827X(99)00067-1
Ali MA, Kondo K, Tsuda Y (1992) Synthesis and nematocidal activity of hydroxystilbenes. Chem Pharm Bull 40:1130–1136. doi:10.1248/cpb.40.1130
Boonlaksiri C, Oonanant W, Kongsaeree P, Kittakoop P, Tanticharoen M, Thebtaranonth Y (2000) An antimalarial stilbene from Artocarpus integer. Phytochem 54:415–417. doi:10.1016/S0031-9422(00)00074-1
Gao M, Wang M, Miller KD, Sledge GW, Hutchins GD, Zheng QH (2006) Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptors in cancer. Bioorg Med Chem Lett 16:5767–5772. doi:10.1016/j.bmcl.2006.08.088
Zheng J, Ramirez VD (1999) Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex. Biochem Biophys Res Commun 261:499–503. doi:10.1006/bbrc.1999.1063
Cai YJ, Fang JG, Ma LP, Yang L, Liu ZL (2003) Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochem Biophys Acta 1637:31–38. doi:10.1016/S0925-4439(02)00174-6
Matsuda H, Morikawa T, Toguchida I, Park JY, Harima S, Yoshikawa M (2001) Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides. Bioorg Med Chem 9:41–50. doi:10.1016/S0968-0896(00)00215-7
Wang LX, Heredia A, Song H, Zhang Z, Yu B, Davis C, Redfield R (2004) Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. J Pharm Sci 93:2448–2457. doi:10.1002/jps.20156
Likhitwitayawuid K, Sritularak B, Benchanak K, Lipipun V, Mathew J, Schinazi RF (2005) Phenolics with antiviral activity from Millettia erythrocalyx and Artocarpus lakoocha. Nat Prod Res 19:177–182. doi:10.1080/14786410410001704813
Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, De Lucia AL (1999) Resveratrol inhibition of herpes simplex virus replication. Antivir Res 43:145–155. doi:10.1016/S0166-3542(99)00042-X
Thakkar K, Geahlen RL, Cushman M (1993) Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogs of piceatannol. J Med Chem 36:2950–2955. doi:10.1021/jm00072a015
Giraud A, Provot O, Hamze A, Brion JD, Alami M (2008) One-pot hydrosilylation–protodesilylation of functionalized diarylalkynes: a highly selective access to \(Z\)-stilbenes. Application to the synthesis of combretastatin A-4. Tetrahedron Lett 49:1107–1110. doi:10.1016/j.tetlet.2007.12.057
Simoni D, Invidiata FP, Eleopra M, Marchetti P, Rondanin R, Baruchello R, Grisolia G, Tripathi A, Kellogg GE, Durrant D, Lee RM (2009) Design, synthesis and biological evaluation of novel stilbene-based antitumor agents. Bioorg Med Chem 17:512–522. doi:10.1016/j.bmc.2008.12.002
Wyrzykiewicz E, Wendzonka M, Kedzia B (2006) Synthesis and antimicrobial activity of new (\(E)\)-4-[piperidino(4’-methylpiperidino-, morpholino-) \(N\)-alkoxy]stilbene. Eur J Med Chem 41:519–525. doi:10.1016/j.ejmech.2005.11.010
Schiffer HH, Reding EC, Fuhs SR, Lu Q, Piu F, Wong S, Littler PLH, Weiner DM, Keefe W, Tan PK, Nash NR, Knapp AE, Olsson R, Brann MR (2007) Pharmacology and signaling properties of epidermal growth factor receptor isoforms studied by bioluminescence resonance energy transfer. Mol Pharm 71:508–518. doi:10.1124/mol.106.027656
Larrosa M, Tomas-Barberan FA, Espin JC (2003) Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J Agric Food Chem 51:4576–4584. doi:10.1021/jf030073c
Yan J, Guo Y, Wang W, Mao F, Huang L, LI X (2015) Design, synthesis and biological evaluation of benzoselenazole-stilbene hybrid as multi-target-directed anticancer agents. Eur J Med Chem 95:220–229. doi:10.1016/j.ejmech.2015.03.030
Keylor MH, Matsuura BS, Stephenson CR (2015) Chemistry and biology of resveratrol-derived natural products. Chem Rev 115:8976–9027. doi:10.1021/cr500689b
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783–2840. http://ar.iiarjournals.org/content/24/5A/2783.full.pdf+html
de Medina P, Casper R, Savouret JF, Poirot M (2005) Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators. J Med Chem 48:287–291. doi:10.1021/jm0498194
Sinha AK, Kumar V, Sharma A, Sharma A, Kumar R (2007) An unusual, mild and convenient one-pot two-step access to (\(E)\)-stilbenes from hydroxy-substituted benzaldehydes and phenylacetic acids under microwave activation: a new facet of the classical perkin reaction. Tetrahedron 63:11070–11077. doi:10.1016/j.tet.2007.08.034
Chaudhary A, Pandeya SN, Kumar P, Sharma PP, Gupta S, Soni N, Verma KK, Bhardwaj G (2007) Combretastatin A-4 analogs as anticancer agents. Mini Rev Med Chem 12:1186–1205. doi:10.2174/138955707782795647
Nam NH (2003) Combretastatin A-4 analogues as antimitotic antitumor agents. Curr Med Chem 10:1697–1722. doi:10.2174/0929867033457151
Horsman MR, Bohn AB, Busk M (2010) Vascular targeting therapy: potential benefit depends on tumor and host related effects. Exp Oncol 32:143–148
Robinson JE, Taylor RJK (2007) A Ramberg–Bäcklund route to the stilbenoid anti-cancer agents combretastatin A-4 and DMU-212. Chem Commun 16:1617–1619. doi:10.1039/B702411H
Alonso F, Riente P, Yus M (2009) Synthesis of resveratrol, DMU-212 and analogues through a novel Wittig-type olefination promoted by nickel nanoparticles. Tetrahedron Lett 50:3070–3073. doi:10.1016/j.tetlet.2009.04.023
McNulty J, Mcleod D (2011) An iterative approach toward the synthesis of discrete oligomeric \(p\)-phenylene vinylene organic dyes employing aqueous Wittig chemistry. Tetrahedron Lett 52:5467–5470. doi:10.1016/j.tetlet.2011.08.040
Um SI, Kang Y, Lee JK (2007) The synthesis and properties of triazine–stilbene fluorescent brighteners containing a monophenolic antioxidant. Dyes Pigments 75:681–686. doi:10.1016/j.dyepig.2006.07.018
Grätzel M (2001) Photoelectrochemical cells. Nature 414:338–344. doi:10.1038/35104607
Zhu YC, He DH, Yang ZR (2009) Synthesis and optical properties of two novel stilbene derivatives containing 1,3,4-oxadiazole moiety. Spectrochim Acta Part A Mol Biomol Spectro 72:417–420. doi:10.1016/j.saa.2008.10.011
Likhitwitayawuid K, Sritularak (2001) A new dimeric stilbene with tyrosinase inhibitiory activity from artocarpus gomezianus. J Nat Prod 64:1457–1459. doi:10.1021/np0101806
Momotake A, Arai T (2004) Photochemistry and photophysics of stilbene dendrimers and related compounds. J Photochem Photobiol C Photochem Rev 5:1–25. doi:10.1016/j.jphotochemrev.2004.01.001
Shen T, Wang XN, Lou HX (2009) Natural stilbenes: an overview. Nat Prod Rep 26:916–35. doi:10.1039/B905960A
Reinisalo M, Kårlund A, Koskela A, Kaarniranta K, Karjalainen RO (2015) Polyphenol stilbenes: Molecular mechanisms of defence against Oxidative Stress and Aging-Related Diseases. Oxid Med Cell Longev 2015: Article ID 340520. doi:10.1155/2015/340520
Jørgensen KB (2010) Photochemical oxidative cyclisation of stilbenes and stilbenoids—the mallory-reaction. Molecules 15:4334–4358. doi:10.3390/molecules15064334
Savage AM, Zhou X, Huang J, Turner SR (2015) A review of semi-rigid, stilbene-containing alternating copolymers. Appl Petrochem Res 5:27–33. doi:10.1007/s13203-014-0055-0
Chong J, Poutaraud A, Hugueney P (2009) Metabolism and roles of stilbenes in plants. Plant Sci 177:143–155. doi:10.1016/j.plantsci.2009.05.012
Waldeck DH (1991) Photoisomerization dynamics of stilbenes. Chem Rev 91:415–436. doi:10.1021/cr00003a007
Bhat KP, Pezzuto JM (2002) Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci 957:210–229. doi:10.1111/j.1749-6632.2002.tb02918.x
Paul S, Mizuno CS, Lee HJ, Zheng X, Chajkowisk S, Rimoldi JM, Conney A, Suh N, Rimando AM (2010) In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer. Eur J Med Chem 45:3702–3708. doi:10.1016/j.ejmech.2010.05.019
Mizuno CS, Ma G, Khan S, Patny A, Avery MA, Rimando AM (2008) Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPAR\(\alpha \). Bioorg Med Chem 16:3800–3808. doi:10.1016/j.bmc.2008.01.051
Das BC, Zhao X, Tang XY, Yang F (2011) Design, synthesis and biological study of pinacolyl boronate-substituted stilbenes as novel lipogenic inhibitors. Bioorg Med Chem Lett 21:5638–5641. doi:10.1016/j.bmcl.2011.05.124
Srivastava V, Lee H (2015) Synthesis and bio-evaluation of novel quinolino-stilbene derivatives as potential anticancer agents. Bioorg Med Chem 23:7629–7640. doi:10.1016/j.bmc.2015.11.007
Jung M, Lee Y, Park M, Kim H, Kim H, Lim E, Tak J, Sim M, Lee D, Park N, Oh WK, Hur KY, Kang ES, Lee YC (2007) Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 17:4481–4486. doi:10.1016/j.bmcl.2007.06.016
Jung JC, Lim E, Lee Y, Kang JM, Kim H, Jang S, Oh S, Jung M (2009) Synthesis of novel trans-stilbene derivatives and evaluation of their potent antioxidant and neuroprotective effects. Eur J Med Chem 44:3166–3174. doi:10.1016/j.ejmech.2009.03.011
Achalkumar AS, Yelamaggad CV (2012) Light emitting, star-shaped tris(\(N\)-salicylideneaniline) discotic liquid crystals bearing trans-stilbene fluorophores: synthesis and characterization. Tetrahedron Lett 53:7108–7112. doi:10.1016/j.tetlet.2012.10.090
Belluti F, Fontana G, Bo LD, Carenini N, Giommarelli C, Zunino F (2010) Design, synthesis and anticancer activities of stilbene–coumarin hybrid compounds: identification of novel proapoptotic agents. Bioorg Med Chem 18:3543–3550. doi:10.1016/j.bmc.2010.03.069
McNulty J, McLeod D (2013) A scalable process for the synthesis of (\(E)\)-pterostilbene involving aqueous Wittig olefination chemistry. Tetrahedron Lett 54:6303–6306. doi:10.1016/j.tetlet.2013.09.019
Li X, He D (2012) Synthesis and optical properties of novel anthracene-based stilbene derivatives containing an 1,3,4-oxadiazole unit. Dyes Pigment 93:1422–1427. doi:10.1016/j.dyepig.2011.10.004
Lu H, He D (2014) Asymmetric 1,3,4-oxadiazole derivatives containing naphthalene and stilbene units: synthesis, optical and electrochemical properties. Spectrochim Acta A 124:91–96. doi:10.1016/j.saa.2013.12.104
Lu H, He D (2014) Novel 2-(naphthalen-1-yl)-5-stilbene-1,3,4-oxadiazole molecules: synthesis, optical properties and DFT calculation. J Mol Struct 1060:88–93. doi:10.1016/j.molstruc.2013.12.022
Zhu YC, Lu HX, He DH, Yang HR (2013) Synthesis, fluorescence properties and applications of two novel oxadiazole-based stilbene optical brighteners as UV protectants for insect baculovirus. J Photoch Photobiol B 125:8–12. doi:10.1016/j.jphotobiol.2013.04.006
Hahm SG, Lee SW, Lee TJ, Cho SA, Chae B, Jung YM, Kim SB, Re M (2008) UV-driven switching of chain orientation and liquid crystal alignment in nanoscale thin films of a novel polyimide bearing stilbene moieties in the backbone. J Phys Chem B 112:4900–4912. doi:10.1021/jp7101868
Mahdavi M, Pedrood K, Safavi M, Saeedi M, Pordeli M, Ardestani SK, Emami S, Adib M, Foroumadi A, Shafiee A (2015) Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold. Eur J Med Chem 95:492–499. doi:10.1016/j.ejmech.2015.03.057
Martí-Centelles R, Cejudo-Marín R, Falomir E, Murga J, Carda M, Marco JA (2013) Inhibition of VEGF expression in cancer cells and endothelial cell differentiation by synthetic stilbene derivatives. Bioorg Med Chem 21:3010–3015. doi:10.1016/j.bmc.2013.03.072
Reddy MA, Jain N, Yada D, Kishore C, Reddy VJ, Reddy PS, Addlagatta A, Kalivendi SV, Sreedhar B (2011) Design and synthesis of resveratrol-based nitrovinylstilbenes as antimitotic agents. J Med Chem 54:6751–6760. doi:10.1021/jm200639r
Albert S, Horbach R, Deising HB, Siewert B, Csuk R (2011) Synthesis and antimicrobial activity of (\(E)\) stilbene derivatives. Bioorg Med Chem 19:5155–5166. doi:10.1016/j.bmc.2011.07.015
Li HJ, Wang L (2006) Triethanolamine as an efficient and reusable base, ligand and reaction medium for phosphane-free palladium-catalyzed heck reactions. Eur J Org Chem 22:5099–5102. doi:10.1002/ejoc.200600561
Khan ZA, Iwaoka M, Wirth T (2010) Novel cyclization cascades to functionalized indanes and tetrahydronaphthalenes. Tetrahedron 66:6639–6646. doi:10.1016/j.tet.2010.03.062
Takai K, Nitta K, Utimoto K (1986) Simple and selective method for aldehydes (RCHO).fwdarw. (\(E)\)-haloalkenes (RCH:CHX) conversion by means of a haloform-chromous chloride system. J Am Chem Soc 108:7408–7410. doi:10.1021/ja00283a046
McDonald O, Lackey K, Davis-Ward R, Wood E, Samano V, Maloney P, Deanda F, Hunter R (2006) Aza-stilbenes as potent and selective c-RAF inhibitors. Bioorg Med Chem Lett 16:5378–5383. doi:10.1016/j.bmcl.2006.07.063
Lara-Ochoa F, Sandoval-Minero LC, Espinosa-Pérez G (2015) A new synthesis of resveratrol. Tetrahedron Lett 56:5977–5979. doi:10.1016/j.tetlet.2015.09.005
Pawluc P, Hreczycho G, Suchecki A, Kubicki M, Marciniec B (2009) Cyclic 1,1-bis(silyl)alkenes-new building blocks for the stereoselective synthesis of unsymmetrical (\(E)\)-stilbenes and (E, E)-1,4-diarylbuta-1,3-dienes. Tetrahedron 65:5497–5502. doi:10.1016/j.tet.2009.01.113
Saiyed AS, Bedekar AV (2010) One-pot synthesis of stilbenes by dehydrohalogenation-Heck olefination and multicomponent Wittig–Heck reaction. Tetrahedron Lett 51:6227–6231. doi:10.1016/j.tetlet.2010.09.050
Cella R, Stefani HA (2006) Ultrasound-assisted synthesis of \(Z\) and \(E\) stilbenes by Suzuki cross-coupling reactions of organotellurides with potassium organotrifluoroborate salts. Tetrahedron 62:5656–5662. doi:10.1016/j.tet.2006.03.090
Karakus M, Nurioglu AG, Akpinar HZ, Toppare L, Cirpan A (2013) Synthesis and electrochromic properties of trans-stilbene bearing copolymers obtained with different repeat unit and chain length. Electrochim Acta 100:110–117. doi:10.1016/j.electacta.2013.03.159
Zhang Y, Shen M, Cui S, Hou T (2014) Synthesis and antiproliferative evaluation of 2-hydroxylated (\(E)\)-stilbenes. Bioorg Med Chem Lett 24:5470–5472. doi:10.1016/j.bmcl.2014.10.009
Shahzad SA, Wirth T (2009) Fast synthesis of benzofluorenes by selenium-mediated carbocyclizations. Angew Chem Int Ed 48:2588–2591. doi:10.1002/anie.200806148
Shahzad SA, Vivant C, Wirth T (2010) Selenium-mediated synthesis of biaryls through rearrangement. Org Lett 12:1364–1367. doi:10.1021/ol100274e
Shahzad SA, Venin C, Wirth T (2010) Diselenide- and disulfide-mediated synthesis of isocoumarins. Eur J Org Chem. doi:10.1002/ejoc.201000308
Kachhadia V, Rajagopal S, Ponpandian T, Vignesh R, Anandhan K, Prabhu D, Rajendran P, Nidhyanandan S, Roy AM, Ahamed FA, Surendran N, Rajagopal S, Narayanan S, Gopalan B (2016) Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts. Eur J Med Chem 108:274–286. doi:10.1016/j.ejmech.2015.11.014
Chanawanno K, Chantrapromma S, Anantapong T, Kanjana-Opas A, Fun HK (2010) Synthesis, structure and in vitro antibacterial activities of new hybrid disinfectants quaternary ammonium compounds: Pyridinium and quinolinium stilbene benzenesulfonates. Eur J Med Chem 45:4199–4208. doi:10.1016/j.ejmech.2010.06.014
Kumar V, Sharma A, Sharma A, Sinha AK (2007) Remarkable synergism in methylimidazole-promoted decarboxylation of substituted cinnamic acid derivatives in basic water medium under microwave irradiation: a clean synthesis of hydroxylated (\(E)\)-stilbenes. Tetrahedron 63:7640–7646. doi:10.1016/j.tet.2007.05.046
Wyrzykiewicz E, Wendzonka M (2004) Synthesis and physicochemical characterization of fluorescent (E)-2-stilbenyloxyalkylthiouracils and isomer differentiation using EIMS. J Heterocycl Chem 41:177–186. doi:10.1002/jhet.5570410207
Chang MY, Chen YC, Lin SY, Chan CK (2014) One-pot synthesis of sulfonyl (\(E)\)-stilbenes by nitrobenzene mediated dimerizative desulfonation of benzylic sulfones. Tetrahedron 70:1740–1747. doi:10.1016/j.tet.2014.01.045
Hussain M, Shamey R, Hinks D, El-Shafei A, Ali SI (2012) Synthesis of novel stilbene-alkoxysilane fluorescent brighteners, and their performance on cotton fiber as fluorescent brightening and ultraviolet absorbing agents. Dyes Pigment 92:1231–1240. doi:10.1016/j.dyepig.2011.06.034
Um SI, Lee JK, Kang Y, Baek DJ (2005) The synthesis and properties of triazine–stilbene fluorescent brighteners containing the phenolic antioxidant. Dyes Pigment 64:93–99. doi:10.1016/j.dyepig.2004.04.008
Um SI, Lee JK, Kang Y, Baek DJ (2006) The synthesis and properties of triazine–stilbene fluorescent brighteners containing the phenolic antioxidant [II]. Dyes Pigment 70:84–90. doi:10.1016/j.dyepig.2005.04.005
Buruiana EC, Zamfir M, Buruiana T (2007) Synthesis, characterization and fluorescence study of new polyacrylates containing stilbene. Eur Polym J 43:4316–4324. doi:10.1016/j.eurpolymj.2007.06.049
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khan, Z.A., Iqbal, A. & Shahzad, S.A. Synthetic approaches toward stilbenes and their related structures. Mol Divers 21, 483–509 (2017). https://doi.org/10.1007/s11030-017-9736-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-017-9736-9